ClinicalTrials.govpublic full text
VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
prevention of zika infection, zika-specific immune response, zika infection, immune response, flavivirus, arthropod-borne virus, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 852813
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.